Suppr超能文献

孕34周后使用产前糖皮质激素时我们应谨慎行事。

We Should Proceed With Caution When It Comes to Antenatal Corticosteroids After 34 Weeks.

作者信息

Nowik Christina M, Davies Gregory A L, Smith Graeme N

机构信息

Department of Obstetrics and Gynaecology, Kingston General Hospital, Kingston ON.

出版信息

J Obstet Gynaecol Can. 2017 Jan;39(1):49-51. doi: 10.1016/j.jogc.2016.05.011. Epub 2016 Dec 10.

Abstract

The Society for Maternal-Fetal Medicine recently released a statement supporting the use of antenatal corticosteroids for women at high risk of late preterm birth. This followed a trend of increasing use of antenatal corticosteroids after 34 weeks' gestation, based on evidence for decreased respiratory morbidity. The absolute benefits, however, are relatively small. We should balance this against the possible long-term harms of corticosteroids after 34 weeks before expanding the indications for their antenatal use.

摘要

母胎医学会最近发布了一份声明,支持对晚期早产高危女性使用产前糖皮质激素。这是基于34周妊娠后呼吸疾病发病率降低的证据,使用产前糖皮质激素的趋势不断增加之后的举措。然而,绝对益处相对较小。在扩大其产前使用指征之前,我们应权衡这一点与34周后糖皮质激素可能带来的长期危害。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验